Medicare Enrolled
Dr. Karan Bhalla, MD
Interventional Cardiology · Pasadena, TX
Practice pattern: Cardiac & Remote— Practice combining cardiac and remote services
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bhalla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bhalla? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bhalla
Dr. Karan Bhalla is an interventional cardiology in Pasadena, TX, with 19 years in practice. Based on federal Medicare data, Dr. Bhalla performed 12,284 Medicare services across 6,866 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bhalla received a total of $47,773 from 53 pharmaceutical and/or device companies across 748 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bhalla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 1% volume in TX$ $47,773 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,284
Medicare services
Top 1% in TX for interventional cardiology
6,866
Unique beneficiaries
$172
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~647 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test | 1,962 | $44 | $318 |
| Office visit, established patient (30-39 min) | 1,645 | $98 | $225 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 1,043 | $29 | $250 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 837 | $21 | $125 |
| Electrocardiogram (EKG), 12-lead | 651 | $11 | $55 |
| Echocardiogram, transthoracic | 568 | $144 | $800 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 546 | $54 | $394 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 513 | $286 | $1,015 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 474 | $1,960 | $5,493 |
| Nuclear medicine study of heart muscle blood flow by pet | 372 | $148 | $599 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 341 | $129 | $615 |
| Ultrasound of leg arteries or artery grafts | 327 | $193 | $815 |
| Ultrasound study of arm and leg arteries | 323 | $53 | $276 |
| Ultrasound of both sides of head and neck blood flow | 300 | $134 | $635 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 296 | $20 | $150 |
| Remote pacemaker/defibrillator monitoring, 90 days | 259 | $17 | $165 |
| Programming of cardiac rhythm monitor system | 204 | $47 | $100 |
| Remote pacemaker monitoring, 90 days | 175 | $23 | $150 |
| Office visit, established patient (20-29 min) | 130 | $56 | $200 |
| Ultrasonic guidance for blood vessel access | 111 | $12 | $100 |
| New patient office visit (45-59 min) | 92 | $123 | $300 |
| Cardiac catheterization | 89 | $189 | $2,000 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 85 | $29 | $165 |
| Programming of dual lead pacemaker system | 83 | $59 | $103 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 75 | $128 | $469 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 71 | $21 | $64 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 70 | $356 | $1,800 |
| Prothrombin time test (blood clotting) | 64 | $4 | $15 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 60 | $686 | $1,000 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 59 | $933 | $8,500 |
| Programming of multiple lead implantable defibrillator system | 53 | $80 | $218 |
| Blood draw (venipuncture) | 52 | $8 | $50 |
| Insertion of heart rhythm monitor under skin | 44 | $3,576 | $15,000 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 37 | $120 | $477 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 35 | $22 | $95 |
| Coronary stent placement | 29 | $478 | $5,000 |
| Office visit, established patient, complex (40-54 min) | 29 | $141 | $352 |
| Injection of chemical agent into multiple incompetent veins of leg | 27 | $181 | $1,114 |
| Programming of dual lead implantable defibrillator system | 26 | $67 | $176 |
| Programming of multiple lead pacemaker system | 19 | $69 | $103 |
| Hospital follow-up visit, moderate complexity | 18 | $65 | $176 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 17 | $150 | $960 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 15 | $89 | $375 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 14 | $59 | $242 |
| Insertion of tube into aorta | 11 | $57 | $440 |
| Review by radiologist of abdominal aorta image | 11 | $55 | $1,500 |
| Review by radiologist of both arms or legs arteries image | 11 | $75 | $1,200 |
| Ultrasound scan of abdominal aorta | 11 | $110 | $295 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.6% high complexity
39.7% medium
48.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$47,773
Total received (2018-2024)
Avg $6,825/year across 7 years
Top 12% in TX for interventional cardiology
53
Companies
748
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,364 (38.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$16,600 (34.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12,810 (26.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$8,396
2023$7,283
2022$2,461
2021$3,572
2020$5,773
2019$5,225
2018$15,063
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$16,437
Medtronic Vascular, Inc.
$12,859
Bard Peripheral Vascular, Inc.
$4,250
BOSTON SCIENTIFIC CORPORATION
$2,308
BARD PERIPHERAL VASCULAR, INC.
$1,349
Cardiovascular Systems Inc.
$1,032
Novartis Pharmaceuticals Corporation
$966
Terumo Medical Corporation
$916
Medtronic, Inc.
$878
Janssen Pharmaceuticals, Inc
$825
Tactile Systems Technology Inc
$745
Venclose Inc.
$580
AstraZeneca Pharmaceuticals LP
$480
PFIZER INC.
$399
Amgen Inc.
$381
Abbott Laboratories
$305
Philips Electronics North America Corporation
$281
Merck Sharp & Dohme LLC
$256
E.R. Squibb & Sons, L.L.C.
$233
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$219
ATRICURE, INC.
$206
Baxter Healthcare
$193
Amarin Pharma Inc.
$183
Boehringer Ingelheim Pharmaceuticals, Inc.
$172
Chiesi USA, Inc.
$143
HeartFlow, Inc.
$138
SANOFI-AVENTIS U.S. LLC
$134
Impulse Dynamics (USA) Inc.
$111
Biosense Webster, Inc.
$110
AngioDynamics, Inc.
$104
Esperion Therapeutics, Inc.
$62
Edwards Lifesciences Corporation
$59
Allergan Inc.
$53
Kiniksa Pharmaceuticals International, plc
$47
Kiniksa Pharmaceuticals, Ltd.
$42
Gilead Sciences, Inc.
$36
Regeneron Healthcare Solutions, Inc.
$33
Actelion Pharmaceuticals US, Inc.
$22
Itamar Medical Inc
$19
MEDICOMP INC
$18
Cook Medical LLC
$18
Ethicon US, LLC
$17
Bracco Diagnostics Inc.
$17
QorumPartners
$17
Novo Nordisk Inc
$17
iRhythm Technologies, Inc.
$16
Lexicon Pharmaceuticals, Inc.
$16
CORDIS US CORP.
$14
GE Healthcare
$12
Bardy Diagnostics, Inc.
$12
Biocompatibles, Inc.
$12
Merck Sharp & Dohme Corporation
$11
EKOS Corporation
$11
Top 3 companies account for 70.2% of total payments
Associated products mentioned in payments ›
ACCOLADE · ACCOLADE SR · ACUITY Steerable · ATRICLIP LAA EXCLUSION SYSTEM · AZUR · Arcalyst · Auryon Laser System 100-120 Vac · BRILINTA · BRITE TIP RADIANZ · BYSTOLIC · BodyGuardian · CARTO 3 · CHANTIX · CLOSUREFAST · COMET · COREVALVE EVOLUT R · Cardiac Monitor · Cardiogen-82 · Carnation Ambulatory Monitor · Chocolate PTA Balloon · ClosureFast · ClosureRFS · Coala Heart Monitor · Concerto · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · EASYTRAK 3 · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · EKOSONIC · ELIQUIS · ELUVIA · EMBLEM · EMBLEM MRI S-ICD · EMERGE · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · ESSENTIO SR · EVRSF · FARXIGA · FFRct · FINELINE II Sterox · FLEXITOUCH · Flexitouch Plus · GENERAL ATHERECTOMY · GENERAL BRADY · GENERAL EP · GENERAL TACHY · GENERAL THERAPIES · GENERAL BRADY · GENERAL VASCULAR INTERVENTION · GENERAL - BRADY · GENERAL - VASCULAR INTERVENTION · GENERAL BRADY · GUIDEZILLA · General - Angiography · General - Therapies · General - Vascular Intervention · HawkOne · HeartMate 3 Left Ventricular Dev · Hillrom - Carnation Ambulatory Monitor · IGT D Peripheral · IN.PACT AV · IN.PACT Admiral · INTELLAMAP ORION · INVOKANA · Inpefa · JARDIANCE · KENGREAL · LATITUDE · LATITUDE CLARITY · LATITUDE Communicator Power Supply · LEQVIO · LIFESTENT · LUTONIX · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MULTAQ · NEXLETOL · OPTIMIZER · Optis Coronary Imaging System · Ozempic · PRADAXA · PRALUENT · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · RESONATE · REVEAL LINQ · RHYTHMIA · ROTABLATOR · ROTAPRO · Repatha · Resolute · Reveal LINQ · Rhythmia Mapping System · S-ICD System Magnet · SAPIEN 3 Ultra RESILIA · SURGIFLO Hemostatic Matrix Family of Products · SYNERGY · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · ULTRASCORE · UPTRAVI · VALITUDE · VARITHENA · VASCUTRAK · VENASEAL · VENOVO · VERQUVO · VIDA · VIGILANT · VIGILANT X4 CRT-D · VYNDAMAX · Vascepa · VenaSeal · Venclose Maven Catheter · WATCHMAN · WATCHMAN Access System · WOLVERINE · WatchPATONE · XARELTO · ZILVER PTX · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (38%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $389 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
44
Per 100K population
0.9
County median income
$73,104
Nearest hospital
OCEANS BEHAVIORAL HOSPITAL OF PASADENA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bhalla is a cardiac & remote specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (mixed engagement, top 12%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bhalla experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Bhalla performed 1,962 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bhalla receive payments from pharmaceutical companies?
Yes. Dr. Bhalla received a total of $47,773 from 53 companies across 748 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bhalla's costs compare to other interventional cardiologys in Pasadena?
Dr. Bhalla's average Medicare payment per service is $172. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bhalla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Pasadena
Browse interventional cardiologys in Pasadena ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in TX
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in TX
Which TX interventional cardiologys receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Bard Peripheral Vascular, Inc. Payments to Doctors
See all physicians who received payments from Bard Peripheral Vascular, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology